LOL. What has he done?
No approvals. One BLA submission rejected. another that has been shelved for 2 years. Poor data for receptor occupancy. No timeline for FDA resubmission. No EUA. Not even a clear path forward as far as trial priorities. He didn't share any of the interim data despite dangling it for months. Enrollment is anemic. He gets paid a disgusting sum yet complains about how hard they're working AND COMPLETELY HOODWINKED INVESTORS WHEN THEY DIDN'T FULLY DISCLOSE THE TRUE INTENTIONS W/ THE AUTHORIZED SHARES. Amarex, imo, has been an utter failure at every stage. He sold the bulk of his stock while telling everyone else it was worth triple digits. he's "signed" two covid distribution agreements, none of which generated any cash to the company and he's miserably failed securing an uplisting. And he's apparently screwed one of the foremost authorities on this area of science, BP. ...but he sure talks a good game.
he's run one under powered mild/moderate trial and one under powered severe/critical trial. neither of which have been good enough to terminate trials and garner EUA. neither will capture viral load (see regeneron's PR today. apparently, they thought it was a worthy metric as do i).
from my perspective, all he's done is get paid a disgusting sum not tied to any significant milestones. good deal for him.
News 
Market Data 
Discover 
